Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Y2 - CANCER > Biological Basis of Cancer Therapy > Flashcards

Biological Basis of Cancer Therapy Flashcards

1
Q

What are the five most common cancers worldwide?

A
  1. Lung
  2. Breast
  3. Bowel
  4. Prostate
  5. Stomach
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the four main anti-cancer modalities?

A
  • Radiotherapy
  • Chemotherapy
  • Surgery
  • Immunotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List the different types of cytotoxic chemotherapy

A
  • Alkylating agents
  • Pseudoalkylating agents
  • Antimetabolites
  • Anthracyclines
  • Vinca alkaloids and taxanes
  • Topoisomerase inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the main types of targeted therapy for cancer?

A
  • Monoclonal antibodies
  • Small molecule inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the term used to describe chemotherapy that is given: a. Following surgery b. Before surgery

A
  • Adjuvant
  • Neoadjuvant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do alkylating agents work?

What is a risk in using akylating agents?

A

1)

  • They add an alkyl group to the guanine residues in DNA
  • This causes cross-linking of the DNA strands and prevents DNA from uncoiling at replication
  • This then triggers apoptosis (via a DNA checkpoint pathway)
  • It encourages mis-pairing

2)

  • They can result in secondary cancers becuase they cause mis-pairing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name four alkylating agents

A
  1. Chlorambucil
  2. Cyclophosphamide
  3. Dacarbazine
  4. Temozolomide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do pseudoalkylating agents work?

A
  • They have the same mechanism as alkylating agents but use platinum instead of alkyl groups
  • So they add platinum to guanine residues which causes DNA cross-linking which prevents the DNA uncoiling during replication - thereby triggering apoptosis via a checkpoint pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name three pseudoalkylating agents

A
  • Carboplatin
  • Cisplatin
  • Oxaliplatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some side effects of alkylating and pseudoalkylating agents?

A
  • Alopecia (except carboplatin)
  • Nephrotoxicity
  • Neurotoxicity
  • Ototoxicity (platins)
  • Nausea, Vomiting,
  • Diarrhoea
  • Immunosuppression
  • Tiredness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do anti-metabolites work - include 3 types of anti-metabolites?

A
  • They masquerade as purine or pyrimidines leading to inhibition of DNA replication and transcription becuse they incorporate into DNA and cause breakages in the double strands or cause the DNA to be read as errors and cause programmed cell death
  • They can also be folate antagonists (dihydrofolate reductase inhibitors)
  • This blocks DNA replication and transcription
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give six examples of anti-metabolites

A
  1. Methotrexate
  2. 6-mercaptopurine
  3. Capecitabine
  4. Gemcitabine
  5. 5-fluorouracil
  6. Fludarabine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

State some side effects of anti-metabolites

A
  • Alopecia (not 5-fluorouracil or capecitabine)
  • Bone marrow suppression - and associated neutropenia, thrombocytopenia and anaemia
  • Increased risk of neutropenic sepsis
  • Nausea
  • Vomiting
  • Mucositis
  • Diarrhoea
  • Fatigue
  • Palmar-plantar erythrodysesthesia (PPE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do anthracyclines work?

A
  • 3 ways:
    1) They intercalate nucleotides in DNA or RNA sequences - inhibiting transcription and replication
    2) Blocks DNA repair - therefore mutagenic
    3) Create damaging oxygen free radicals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Give two examples of anthracyclines

A
  • Doxorubicin
  • Epirubicin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

State some side effects of anthracyclines

A
  • Cardiac toxicity (probably due to the free radicals)
  • Alopecia
  • Neutropenia
  • Nausea
  • Vomiting
  • Fatigue
  • Red urine (doxorubicin –‘the red devil’)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do vinca alkaloids and taxanes work?

A
  • Vinca alkaloids inhibit assembly of microtubules
  • Taxanes inhibit disassembly of microtubules
  • This forces the cells into mitotic arrest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

State some side effects of vinca alkaloids / taxanes

A
  • Nerve damage (peripheral neuropathy and autonomic neuropathy)
  • Hair loss
  • Nausea
  • Vomiting
  • Bone marrow suppression
  • Arthralgia (severe joint pain without swelling or signs of arthritis)
  • Allergy
19
Q

How do topoisomerase inhibitors work?

A
  • Topoisomerase is responsible for the unwinding of DNA and they induce temporary single and double strand breaks in the phosphodiester backbone in order to allow DNA replication and transcription
  • Topoisomerase inhibitors alter the binding of topoisomerase to DNA and allow permanent breaks in the DNA
  • This is unacceptable DNA damage and results in apoptosis at the DNA checkpoint
20
Q

Give three examples of topoisomerase inhibitors

A
  1. Topotecan
  2. Irinotecan
  3. Etoposide
21
Q

State some side effects of topoisomerase inhibitors

A
  • Irinotecan = acute cholinergic type syndrome (diarrhoea, abdominal cramps, diaphoresis – so they are given atropine)
  • Hair loss
  • Nausea
  • Vomiting
  • Fatigue
  • Bone marrow suppression
22
Q

What are the six hallmarks of cancer?

A

SPINAP

  1. Self-sufficient
  2. Pro-invasive and metastatic
  3. Insensitive to anti-growth signals
  4. Non-senescent
  5. Anti-apoptotic
  6. Pro-angiogenic
23
Q

What are the four hallmarks of cancer that have recently been added?

A

DIE U

  • Dysregulated metabolism
  • Inflammation
  • Evades the immune system
  • Unstable DNA
24
Q

Give three examples of receptors that are over-expressed in cancer and outline the common reason that overexpression of these receptors may result in cancer

A
  1. EGFR – over-expressed in many breast and colorectal cancers
  2. HER2 – breast
  3. PDGFR – glioma (brain)
  • Over-expression → increased kinase cascade → increased signal amplification
25
Q

Give an example of a ligand that is over-expressed in some cancers and why might overexpression of certain ligands cause cancer?

A
  • VEGF – prostate, kidney and breast cancer
  • It increases the activation of the kinase cascade → increased signal amplification
26
Q

What do we mean by constitutive receptor activation and give 2 examples in cancer?

A
  • Ligand-independ receptor activation - in this case in regards receptors which lead into the kinase cascades that end in increased cellular proliferation
  1. EGFR – lung cancer
  2. FGFR – head and neck cancers, myeloma
27
Q

What do each of the following suffixes mean in relation to monoclonal antibodies:

1) -momab
2) -ximab
3) -zumab
4) -mumab

A

1)

–momab Derived from mouse antibodies

2)

–ximab Chimeric antibody

3)

-zumab Humanised antibody

4)

–mumab Fully human antibody

28
Q

Describe the structure of humanised monoclonal antibodies

A
  • Murine regions are interspersed within the light and heavy chains of the Fab portion
29
Q

Describe the structure of chimeric monoclonal antibodies

A
  • The murine component of the variable region of the Fab section is maintained integrally
30
Q

What effect can monoclonal antibodies have on receptors and their activation?

A
  • They target the extracellular component of receptors and can prevent receptor dimerization, neutralise the ligand and cause internalisation of the receptor
  • NOTE: they also activate Fc gamma-receptor-dependent phagocytosis or cytolysis induced complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicity (ADCC)
31
Q

Give two examples of monoclonal antibodies used in oncology

A
  • Bevacizumab (avastin) – binds and neutralises VEGF
  • Cetuximab – targets EGFR
32
Q

How do small molecule inhibitors work?

A
  • They bind to the kinase domain of tyrosine kinase receptors within the cytoplasm and block autophosphorylation and downstream signalling
33
Q

What is a popular small molecule inhibitor chemotherapeutic drug?

A
  • Glivec (imatinib) – it is a small molecule inhibitor that targets the ATP binding region within the kinase domain of BCR-ABL1
  • This inhibits the kinase activity of ABL1
34
Q

Give four examples of small molecule inhibitors that inhibit receptors

A
  1. Erlotinib (EGFR)
  2. Gefitinib (EGFR)
  3. Lapatinib (EGFR/HER2)
  4. Sorafenib (VEGFR)
35
Q

Give three examples of small molecule inhibitors that inhibit intracellular kinases

A
  • Sorafenib (Raf kinase) – this is in addition to its anti-VEGFR effects
  • Dasatinib (Src kinase)
  • Torcinibs (mTOR inhibitors)
36
Q

State some advantages and disadvantages of monoclonal antibodies

A

Advantages:

  • High target specificity
  • Cause ADCC, complement-mediated cytotoxicity and apoptosis induction
  • Can be radiolabelled
  • Long half-life
  • Good for haematological malignancies Disadvantages:
  • Large and complex structure
  • Less useful against bulky tumours
  • Only useful against targets with extracellular domains
  • Not useful for constitutively activated tumours 
  • Cause immunogenicity and allergy
  • IV administration
  • Expensive
37
Q

State some advantages and disadvantages of small molecule inhibitors

A

Advantages:

  • Can target tyrosine kinases without an extracellular domain or which are constitutively activated
  • Pleiotropic targets (useful in heterogenic tumours/cross-talk)
  • Oral administration
  • Good tissue penetration
  • Cheap

Disadvantages:

  • Shorter half-life, more frequent administration
  • Pleiotropic targets (more unexpected toxicity)
38
Q

State some resistance mechanisms to targeted therapies

A
  • Mutations in ATP binding domain in BCR-ABL which Glivec targets for example
  • Intrinsic resistance
  • Intragenic mutations
  • Upregulation of downstream signalling pathways
39
Q

Explain how anti-sense oligonucleotides work

A
  • These are short single-stranded DNA-like molecules
  • They hybridise to the complementary sequence on mRNA and hinder its translation
  • It then recruits RNase H to cleave the target mRNA Mechanism: anti-sense oligonucleotides
40
Q

Name a successful B-Raf inhibitor and mention side effects

A
  • Vemurafenib
  • NOTE: side effects include arthralgia, skin rash and photosensitivity
41
Q

Explain how the PD-1 receptor-PDL1 ligand system works

A
  • PD-1 receptor is on the cell membrane
  • When the ligand (PDL-1) binds to the PD-1 receptor, the body’s T cells can no longer recognise tumours as foreign
  • So blocking the PD-1 receptor will stimulate the immune system
42
Q

Name a drug that inhibitS PD-1

A
  • Nivolumab (anti-PD1 antibody)
43
Q

Give 2 general resistance mechanisms against general therapeutics against cancer

A
  • DNA repair mechanism upregulation e.g. prevent DNA double stranded breakage → cell survival
  • Drugs effluxed from the cell e.g. by ATP-binding cassete (ABC) transporters
44
Q

Describe the mechanism by which cancer can become resistant to treatment that involves DNA adducts

A
  • DNA adducts may be excised by base excision repair (using PARP)

Y2 - CANCER (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions